Jones Financial Companies
NAMS icon

Jones Financial Companies’s NewAmsterdam Pharma NAMS Stock Holding History

Jones Financial Companies’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.58K Sell
168
-362
-68% -$11.9K ﹤0.01% 4048
2026
Q1 		$15.9K Buy
530
+331
+166% +$10.8K ﹤0.01% 3390
2025
Q4 		$6.98K Sell
199
-50
-20% -$1.82K ﹤0.01% 3377
2025
Q3 		$7.1K Hold
249
– – ﹤0.01% 3209
2025
Q2 		$4.62K Buy
+249
New +$4.54K ﹤0.01% 3159

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Jones Financial Companies's NAMS Position: Q2 2026 in Review

Jones Financial Companies reduced its NewAmsterdam Pharma (NAMS) stake by 68% in Q2 2026, selling an estimated $11.9K and leaving 168 shares worth $5.58K. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

Jones Financial Companies first reported a position in NAMS in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.9K in Q1 2026. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Jones Financial Companies held 168 shares of NewAmsterdam Pharma worth $5.58K as of Q2 2026.
  • Jones Financial Companies sold 362 NewAmsterdam Pharma shares in Q2 2026, an estimated $11.9K.
  • NewAmsterdam Pharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4048 holding.
  • Jones Financial Companies first reported a position in NewAmsterdam Pharma in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's NewAmsterdam Pharma position peaked at $15.9K in Q1 2026.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.